Zobrazeno 1 - 10
of 661
pro vyhledávání: '"E. Rohde"'
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Despite the advances in the treatment of HIV, people living with HIV (PLHIV) still experience impairment of health-related quality of life (HRQOL). The aim of the study was to explore factors associated with HRQOL in a well-treate
Externí odkaz:
https://doaj.org/article/4a7f26968e47491196c592d6b7cca4b5
Autor:
Luis E. Rohde, Conrado R. Hoffmann Filho, Marciane M. Rover, Eneida Rejane Rabelo‐Silva, Letícia Lopez, Luiz C.S. Passos, Odilson M. Silvestre, Silvia M. Martins, José A. deFigueiredo Neto, Fábio S. Silveira, Manoel F. Canesin, Marcus V. Simões, Fábio Akio Nishijuka, Eduardo G. Bertoldi, Luiz C. Danzmann, Ricardo Mourilhe‐Rocha, Ellen Hettwer Magedanz, Mauro Esteves, Fábio M. deCastilho, Miguel M. Fernandes‐Silva, Luiz E.F. Ritt, Mariana Blacher, Rafael M. Soares, Alexandre B. Cavalcanti, Felix Ramirez
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5523-5530 (2021)
Abstract Aims To evaluate a telemonitoring strategy based on automated text messaging and telephone support after heart failure (HF) hospitalization. Methods and results The MESSAGE‐HF study is a prospective multicentre, randomized, nationwide tria
Externí odkaz:
https://doaj.org/article/7699de9d20574ab98344e8c5b9672896
Publikováno v:
Geochemistry, Geophysics, Geosystems, Vol 22, Iss 8, Pp n/a-n/a (2021)
Abstract Changes in the circulation of the Southern Ocean are known to have impacted global nutrient, heat, and carbon cycles during the glacial and interglacial periods of the late Pleistocene. Proxy‐based records of these changes deserve continue
Externí odkaz:
https://doaj.org/article/7f5404e188bc4086aca541569e146441
Autor:
James P Curtain, Carly Adamson, Toru Kondo, Jawad Haider Butt, Akshay S Desai, Faiez Zannad, Jean L Rouleau, Luis E Rohde, Lars Kober, Inder S Anand, Dirk J van Veldhuisen, Michael R Zile, Martin P Lefkowitz, Scott D Solomon, Milton Packer, Mark C Petrie, Pardeep S Jhund, John J V McMurray
Publikováno v:
European Heart Journal, 44(8), 668-677. Oxford University Press
AimsFew reports have examined the incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF) or their relationship with mortality in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with pre
Autor:
Mariana R. Botton, Patrícia P. Viola, Mariana R. Meireles, Estela M. Bruxel, Priccila Zuchinali, Eliane Bandinelli, Luis E. Rohde, Tiago L. L. Leiria, Joyce Y. Y. Salamoni, Arthur P. Garbin, Mara H. Hutz
Publikováno v:
Genetics and Molecular Biology, Vol 43, Iss 1 suppl 2 (2020)
Abstract Warfarin is an oral anticoagulant prescribed to prevent and treat thromboembolic disorders. It has a narrow therapeutic window and must have its effect controlled. Prothrombin test, expressed in INR value, is used for dose management. Time i
Externí odkaz:
https://doaj.org/article/43d2e924621442f08f60b901d791fc29
Autor:
Cinara Stein, Lucas Helal, Celina Borges Migliavaca, Caroline Nicola Sangalli, Verônica Colpani, Priscila Raupp da Rosa, Luís Beck-da-Silva, Luis E. Rohde, Carisi Anne Polanczyk, Maicon Falavigna
Publikováno v:
Clinical Nutrition ESPEN. 49:129-137
Heart failure (HF) is a growing problem for healthcare systems worldwide. Sodium and fluid restriction are non-pharmacological treatments recommended for patients with HF by several guidelines over the years, even without consensus.To evaluate the ef
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
James P, Curtain, Alice M, Jackson, Li, Shen, Pardeep S, Jhund, Kieran F, Docherty, Mark C, Petrie, Davide, Castagno, Akshay S, Desai, Luis E, Rohde, Martin P, Lefkowitz, Jean-Lucien, Rouleau, Michael R, Zile, Scott D, Solomon, Karl, Swedberg, Milton, Packer, John J V, McMurray
Publikováno v:
European Journal of Heart Failure. 24:551-561
Sudden death is a leading cause of mortality in heart failure with reduced ejection fraction (HFrEF). In PARADIGM-HF, sacubitril/valsartan reduced the incidence of sudden death. The purpose of this post hoc study was to analyse the effect of sacubitr
Publikováno v:
Journal of American College Health. :1-9
Autor:
Luís Beck-da-Silva, Luís E Rohde
Publikováno v:
The Lancet. 399:1361-1363